🇺🇸 FDA
Patent

US 9687542

Rift valley fever virus replicon particles and use thereof

granted A61KA61K2039/5254A61K2039/5258

Quick answer

US patent 9687542 (Rift valley fever virus replicon particles and use thereof) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5254, A61K2039/5258, A61K39/12, A61P